Literature DB >> 22946726

Mitochondrial diseases and epilepsy.

Laurence A Bindoff1, Bernt A Engelsen.   

Abstract

The mitochondrial respiratory chain is the final common pathway for energy production. Defects affecting this pathway can give rise to disease that presents at any age and affects any tissue. However, irrespective of genetic defect, epilepsy is common and there is a significant risk of status epilepticus. This review summarizes our current understanding of the epilepsy that occurs in mitochondrial disease, focusing on three of the most common disorders: mitochondrial myopathy encephalopathy, lactic acidosis and stroke-like episodes (MELAS), myoclonus epilepsy and ragged-red fibers (MERRF), and polymerase gamma (POLG) related disease. In addition, we review the pathogenesis and possible treatment of these disorders. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22946726     DOI: 10.1111/j.1528-1167.2012.03618.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  39 in total

Review 1.  Movement disorders in mitochondrial disease.

Authors:  Roula Ghaoui; Carolyn M Sue
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

2.  Bayesian network and mechanistic hierarchical structure modeling of increased likelihood of developing intractable childhood epilepsy from the combined effect of mtDNA variants, oxidative damage, and copy number.

Authors:  Brenda Luna; Sanjiv Bhatia; Changwon Yoo; Quentin Felty; David I Sandberg; Michael Duchowny; Ziad Khatib; Ian Miller; John Ragheb; Jayakar Prasanna; Deodutta Roy
Journal:  J Mol Neurosci       Date:  2014-07-16       Impact factor: 3.444

3.  MELAS syndrome diagnosed in ICU in a 56-year-old patient presenting with status epilepticus.

Authors:  Charikleia S Vrettou; Dimitrios Zervakis; Andreas Priovolos; Sofia Koskina; Magdalini Tsamouri; Christina Routsi
Journal:  Intensive Care Med       Date:  2013-03-28       Impact factor: 17.440

Review 4.  Neuromuscular and systemic presentations in adults: diagnoses beyond MERRF and MELAS.

Authors:  Bruce H Cohen
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 5.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 6.  Nutritional and Bioenergetic Considerations in Critically Ill Patients with Acute Neurological Injury.

Authors:  Peter A Abdelmalik; Susan Dempsey; Wendy Ziai
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

7.  Fast mitochondrial DNA isolation from mammalian cells for next-generation sequencing.

Authors:  Wilber Quispe-Tintaya; Ryan R White; Vasily N Popov; Jan Vijg; Alexander Y Maslov
Journal:  Biotechniques       Date:  2013-09       Impact factor: 1.993

8.  Novel Vitamin K analogs suppress seizures in zebrafish and mouse models of epilepsy.

Authors:  J J Rahn; J E Bestman; B J Josey; E S Inks; K D Stackley; C E Rogers; C J Chou; S S L Chan
Journal:  Neuroscience       Date:  2013-12-01       Impact factor: 3.590

9.  Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2013-06-28       Impact factor: 4.406

10.  The role of astrocytes in seizure generation: insights from a novel in vitro seizure model based on mitochondrial dysfunction.

Authors:  Felix Chan; Nichola Z Lax; Caroline Marie Voss; Blanca Irene Aldana; Shuna Whyte; Alistair Jenkins; Claire Nicholson; Sophie Nichols; Elizabeth Tilley; Zoe Powell; Helle S Waagepetersen; Ceri H Davies; Doug M Turnbull; Mark O Cunningham
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.